MoonLake ImmunotherapeuticsHere is the public summary page for MoonLake Immunotherapeutics. Please login to see the complete information for MoonLake Immunotherapeutics including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how MoonLake Immunotherapeutics stacks up relative to its peers. |
| Darwin Score | +15 |
| Ticker | MLTX |
| Latest Price | 50.46 USD as of close on 30-Jul-2025 |
| 3 Month price range | 32.84 to 51.05 USD |
| Market Capitalisation | 3.10Bn USD |
| Country | Switzerland |
| Region | Europe |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Sub-Industry | Biotechnology |
| Description | MoonLake Immunotherapeutics, a clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland. See More ... |
| Company URL | https://www.moonlaketx.com |
| See Darwins Full Analysis for MoonLake Immunotherapeutics |
Tell Me About
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for MoonLake Immunotherapeutics. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | +10 |
| Sentiment | News and Candle Patterns. | 0 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | +3 |
| Flow | Institutional, Fund and Insider buying and selling. | -1 |
| Models | Forecast models. | +3 |
Share 
